For an illness like cancer, doctors often turn to computed tomography (CT) scans for a more definitive diagnosis, based on reconstructing a 3-D organ from multiple 2-D image slices. At the molecular level, such 3-D scans could become an important part of precision medicine: a future of tailoring treatment decisions to each patient’s unique cellular features.